Home > > > > Report Detail

Global Transmucosal Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 06-Oct-2022
No. of pages: 131
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Transmucosal Drug Delivery companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Transmucosal Drug Delivery market. Further, it explains the major drivers and regional dynamics of the global Transmucosal Drug Delivery market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- 3M Pharmaceuticals

- Acrux Limited

- ALZA Corporation

- Antares Pharma, Inc.

- Apricus BioSciences, Inc

- Aveva Drug Delivery Systems

- Corium International, Inc

- DURECT Corporation

- Generex Biotechnology Corporation

- Inovio Pharmaceuticals, Inc.

- Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)

- MedPharm LTD

- Mylan, Inc.

- Nemaura Pharma Ltd

- Nitto Denko Corporation

- Noven Pharmaceuticals, Inc.

- Pantec Biosolutions AG

- Tapemark

- tesa Labtec GmbH

- TEVA Pharmaceutical Industries Ltd.

- Zosano Pharma

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Transmucosal Drug Delivery Segment by Type

- Passive Transdermal Drug Delivery

- Active Transdermal Drug Delivery

Transmucosal Drug Delivery Segment by Application

- Hospital

- Clinic

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Transmucosal Drug Delivery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Transmucosal Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Transmucosal Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Transmucosal Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transmucosal Drug Delivery revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Transmucosal Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Transmucosal Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including 3M Pharmaceuticals, Acrux Limited, ALZA Corporation, Antares Pharma, Inc., Apricus BioSciences, Inc, Aveva Drug Delivery Systems, Corium International, Inc, DURECT Corporation and Generex Biotechnology Corporation, etc.

Global Transmucosal Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Passive Transdermal Drug Delivery
1.2.3 Active Transdermal Drug Delivery
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Transmucosal Drug Delivery Market Size (2017-2028)
2.2 Transmucosal Drug Delivery Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Transmucosal Drug Delivery Market Size by Region (2017-2022)
2.4 Global Transmucosal Drug Delivery Market Size Forecast by Region (2023-2028)
2.5 Global Top Transmucosal Drug Delivery Countries Ranking by Market Size
3 Transmucosal Drug Delivery Competitive by Company
3.1 Global Transmucosal Drug Delivery Revenue by Players
3.1.1 Global Transmucosal Drug Delivery Revenue by Players (2017-2022)
3.1.2 Global Transmucosal Drug Delivery Market Share by Players (2017-2022)
3.2 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Transmucosal Drug Delivery Revenue
3.4 Global Transmucosal Drug Delivery Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2021
3.5 Global Transmucosal Drug Delivery Key Players Head office and Area Served
3.6 Key Players Transmucosal Drug Delivery Product Solution and Service
3.7 Date of Enter into Transmucosal Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Transmucosal Drug Delivery Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Historic Revenue by Type (2017-2022)
4.2 Global Transmucosal Drug Delivery Forecasted Revenue by Type (2023-2028)
5 Global Transmucosal Drug Delivery Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Transmucosal Drug Delivery Revenue by Company (2020-2022)
6.2 North America Transmucosal Drug Delivery Revenue by Type (2017-2028)
6.3 North America Transmucosal Drug Delivery Revenue by Application (2017-2028)
6.4 North America Transmucosal Drug Delivery Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Revenue by Company (2020-2022)
7.2 Europe Transmucosal Drug Delivery Revenue by Type (2017-2028)
7.3 Europe Transmucosal Drug Delivery Revenue by Application (2017-2028)
7.4 Europe Transmucosal Drug Delivery Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Transmucosal Drug Delivery Revenue by Company (2020-2022)
8.2 Asia Pacific Transmucosal Drug Delivery Revenue by Type (2017-2028)
8.3 Asia Pacific Transmucosal Drug Delivery Revenue by Application (2017-2028)
8.4 Asia Pacific Transmucosal Drug Delivery Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Transmucosal Drug Delivery Revenue by Company (2020-2022)
9.2 Latin America Transmucosal Drug Delivery Revenue by Type (2017-2028)
9.3 Latin America Transmucosal Drug Delivery Revenue by Application (2017-2028)
9.4 Latin America Transmucosal Drug Delivery Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Transmucosal Drug Delivery Revenue by Company (2020-2022)
10.2 Middle East and Africa Transmucosal Drug Delivery Revenue by Type (2017-2028)
10.3 Middle East and Africa Transmucosal Drug Delivery Revenue by Application (2017-2028)
10.4 Middle East and Africa Transmucosal Drug Delivery Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 3M Pharmaceuticals
11.1.1 3M Pharmaceuticals Company Details
11.1.2 3M Pharmaceuticals Business Overview
11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Products and Services
11.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.1.5 3M Pharmaceuticals Transmucosal Drug Delivery SWOT Analysis
11.1.6 3M Pharmaceuticals Recent Developments
11.2 Acrux Limited
11.2.1 Acrux Limited Company Details
11.2.2 Acrux Limited Business Overview
11.2.3 Acrux Limited Transmucosal Drug Delivery Products and Services
11.2.4 Acrux Limited Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.2.5 Acrux Limited Transmucosal Drug Delivery SWOT Analysis
11.2.6 Acrux Limited Recent Developments
11.3 ALZA Corporation
11.3.1 ALZA Corporation Company Details
11.3.2 ALZA Corporation Business Overview
11.3.3 ALZA Corporation Transmucosal Drug Delivery Products and Services
11.3.4 ALZA Corporation Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.3.5 ALZA Corporation Transmucosal Drug Delivery SWOT Analysis
11.3.6 ALZA Corporation Recent Developments
11.4 Antares Pharma, Inc.
11.4.1 Antares Pharma, Inc. Company Details
11.4.2 Antares Pharma, Inc. Business Overview
11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Products and Services
11.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.4.5 Antares Pharma, Inc. Transmucosal Drug Delivery SWOT Analysis
11.4.6 Antares Pharma, Inc. Recent Developments
11.5 Apricus BioSciences, Inc
11.5.1 Apricus BioSciences, Inc Company Details
11.5.2 Apricus BioSciences, Inc Business Overview
11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Products and Services
11.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.5.5 Apricus BioSciences, Inc Transmucosal Drug Delivery SWOT Analysis
11.5.6 Apricus BioSciences, Inc Recent Developments
11.6 Aveva Drug Delivery Systems
11.6.1 Aveva Drug Delivery Systems Company Details
11.6.2 Aveva Drug Delivery Systems Business Overview
11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Products and Services
11.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.6.5 Aveva Drug Delivery Systems Transmucosal Drug Delivery SWOT Analysis
11.6.6 Aveva Drug Delivery Systems Recent Developments
11.7 Corium International, Inc
11.7.1 Corium International, Inc Company Details
11.7.2 Corium International, Inc Business Overview
11.7.3 Corium International, Inc Transmucosal Drug Delivery Products and Services
11.7.4 Corium International, Inc Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.7.5 Corium International, Inc Transmucosal Drug Delivery SWOT Analysis
11.7.6 Corium International, Inc Recent Developments
11.8 DURECT Corporation
11.8.1 DURECT Corporation Company Details
11.8.2 DURECT Corporation Business Overview
11.8.3 DURECT Corporation Transmucosal Drug Delivery Products and Services
11.8.4 DURECT Corporation Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.8.5 DURECT Corporation Transmucosal Drug Delivery SWOT Analysis
11.8.6 DURECT Corporation Recent Developments
11.9 Generex Biotechnology Corporation
11.9.1 Generex Biotechnology Corporation Company Details
11.9.2 Generex Biotechnology Corporation Business Overview
11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Products and Services
11.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.9.5 Generex Biotechnology Corporation Transmucosal Drug Delivery SWOT Analysis
11.9.6 Generex Biotechnology Corporation Recent Developments
11.10 Inovio Pharmaceuticals, Inc.
11.10.1 Inovio Pharmaceuticals, Inc. Company Details
11.10.2 Inovio Pharmaceuticals, Inc. Business Overview
11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Products and Services
11.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.10.5 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery SWOT Analysis
11.10.6 Inovio Pharmaceuticals, Inc. Recent Developments
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Products and Services
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments
11.12 MedPharm LTD
11.12.1 MedPharm LTD Company Details
11.12.2 MedPharm LTD Business Overview
11.12.3 MedPharm LTD Transmucosal Drug Delivery Products and Services
11.12.4 MedPharm LTD Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.12.5 MedPharm LTD Recent Developments
11.13 Mylan, Inc.
11.13.1 Mylan, Inc. Company Details
11.13.2 Mylan, Inc. Business Overview
11.13.3 Mylan, Inc. Transmucosal Drug Delivery Products and Services
11.13.4 Mylan, Inc. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.13.5 Mylan, Inc. Recent Developments
11.14 Nemaura Pharma Ltd
11.14.1 Nemaura Pharma Ltd Company Details
11.14.2 Nemaura Pharma Ltd Business Overview
11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Products and Services
11.14.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.14.5 Nemaura Pharma Ltd Recent Developments
11.15 Nitto Denko Corporation
11.15.1 Nitto Denko Corporation Company Details
11.15.2 Nitto Denko Corporation Business Overview
11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Products and Services
11.15.4 Nitto Denko Corporation Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.15.5 Nitto Denko Corporation Recent Developments
11.16 Noven Pharmaceuticals, Inc.
11.16.1 Noven Pharmaceuticals, Inc. Company Details
11.16.2 Noven Pharmaceuticals, Inc. Business Overview
11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Products and Services
11.16.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.16.5 Noven Pharmaceuticals, Inc. Recent Developments
11.17 Pantec Biosolutions AG
11.17.1 Pantec Biosolutions AG Company Details
11.17.2 Pantec Biosolutions AG Business Overview
11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Products and Services
11.17.4 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.17.5 Pantec Biosolutions AG Recent Developments
11.18 Tapemark
11.18.1 Tapemark Company Details
11.18.2 Tapemark Business Overview
11.18.3 Tapemark Transmucosal Drug Delivery Products and Services
11.18.4 Tapemark Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.18.5 Tapemark Recent Developments
11.19 tesa Labtec GmbH
11.19.1 tesa Labtec GmbH Company Details
11.19.2 tesa Labtec GmbH Business Overview
11.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Products and Services
11.19.4 tesa Labtec GmbH Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.19.5 tesa Labtec GmbH Recent Developments
11.20 TEVA Pharmaceutical Industries Ltd.
11.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
11.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Products and Services
11.20.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.20.5 TEVA Pharmaceutical Industries Ltd. Recent Developments
11.21 Zosano Pharma
11.21.1 Zosano Pharma Company Details
11.21.2 Zosano Pharma Business Overview
11.21.3 Zosano Pharma Transmucosal Drug Delivery Products and Services
11.21.4 Zosano Pharma Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022)
11.21.5 Zosano Pharma Recent Developments
12 Transmucosal Drug Delivery Market Dynamics
12.1 Transmucosal Drug Delivery Market Trends
12.2 Transmucosal Drug Delivery Market Drivers
12.3 Transmucosal Drug Delivery Market Challenges
12.4 Transmucosal Drug Delivery Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Passive Transdermal Drug Delivery
Table 3. Key Players of Active Transdermal Drug Delivery
Table 4. Global Transmucosal Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Transmucosal Drug Delivery Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Transmucosal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Transmucosal Drug Delivery Revenue Market Share by Region (2017-2022)
Table 8. Global Transmucosal Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Transmucosal Drug Delivery Market Share by Players (2017-2022)
Table 10. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery as of 2021)
Table 11. Ranking of Global Top Transmucosal Drug Delivery Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Transmucosal Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Transmucosal Drug Delivery Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Transmucosal Drug Delivery Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Transmucosal Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Transmucosal Drug Delivery Revenue Market Share by Type (2017-2022)
Table 19. Global Transmucosal Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Transmucosal Drug Delivery Revenue Market Share by Type (2023-2028)
Table 21. Global Transmucosal Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Transmucosal Drug Delivery Revenue Market Share by Application (2017-2022)
Table 23. Global Transmucosal Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Transmucosal Drug Delivery Revenue Market Share by Application (2023-2028)
Table 25. North America Transmucosal Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Transmucosal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Transmucosal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Transmucosal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Transmucosal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Transmucosal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Transmucosal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Transmucosal Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Transmucosal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Transmucosal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Transmucosal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Transmucosal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Transmucosal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Transmucosal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Transmucosal Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Transmucosal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Transmucosal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Transmucosal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Transmucosal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Transmucosal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Transmucosal Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Transmucosal Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Transmucosal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Transmucosal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Transmucosal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Transmucosal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Transmucosal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Transmucosal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Transmucosal Drug Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Transmucosal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Transmucosal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Transmucosal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Transmucosal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Transmucosal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Transmucosal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 60. 3M Pharmaceuticals Company Details
Table 61. 3M Pharmaceuticals Business Overview
Table 62. 3M Pharmaceuticals Transmucosal Drug Delivery Product and Services
Table 63. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 64. 3M Pharmaceuticals Transmucosal Drug Delivery SWOT Analysis
Table 65. 3M Pharmaceuticals Recent Developments
Table 66. Acrux Limited Company Details
Table 67. Acrux Limited Business Overview
Table 68. Acrux Limited Transmucosal Drug Delivery Product and Services
Table 69. Acrux Limited Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 70. Acrux Limited Transmucosal Drug Delivery SWOT Analysis
Table 71. Acrux Limited Recent Developments
Table 72. ALZA Corporation Company Details
Table 73. ALZA Corporation Business Overview
Table 74. ALZA Corporation Transmucosal Drug Delivery Product and Services
Table 75. ALZA Corporation Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 76. ALZA Corporation Transmucosal Drug Delivery SWOT Analysis
Table 77. ALZA Corporation Recent Developments
Table 78. Antares Pharma, Inc. Company Details
Table 79. Antares Pharma, Inc. Business Overview
Table 80. Antares Pharma, Inc. Transmucosal Drug Delivery Product and Services
Table 81. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 82. Antares Pharma, Inc. Transmucosal Drug Delivery SWOT Analysis
Table 83. Antares Pharma, Inc. Recent Developments
Table 84. Apricus BioSciences, Inc Company Details
Table 85. Apricus BioSciences, Inc Business Overview
Table 86. Apricus BioSciences, Inc Transmucosal Drug Delivery Product and Services
Table 87. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 88. Apricus BioSciences, Inc Transmucosal Drug Delivery SWOT Analysis
Table 89. Apricus BioSciences, Inc Recent Developments
Table 90. Aveva Drug Delivery Systems Company Details
Table 91. Aveva Drug Delivery Systems Business Overview
Table 92. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product and Services
Table 93. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 94. Aveva Drug Delivery Systems Transmucosal Drug Delivery SWOT Analysis
Table 95. Aveva Drug Delivery Systems Recent Developments
Table 96. Corium International, Inc Company Details
Table 97. Corium International, Inc Business Overview
Table 98. Corium International, Inc Transmucosal Drug Delivery Product and Services
Table 99. Corium International, Inc Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 100. Corium International, Inc Transmucosal Drug Delivery SWOT Analysis
Table 101. Corium International, Inc Recent Developments
Table 102. DURECT Corporation Company Details
Table 103. DURECT Corporation Business Overview
Table 104. DURECT Corporation Transmucosal Drug Delivery Product and Services
Table 105. DURECT Corporation Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 106. DURECT Corporation Transmucosal Drug Delivery SWOT Analysis
Table 107. DURECT Corporation Recent Developments
Table 108. Generex Biotechnology Corporation Company Details
Table 109. Generex Biotechnology Corporation Business Overview
Table 110. Generex Biotechnology Corporation Transmucosal Drug Delivery Product and Services
Table 111. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 112. Generex Biotechnology Corporation Transmucosal Drug Delivery SWOT Analysis
Table 113. Generex Biotechnology Corporation Recent Developments
Table 114. Inovio Pharmaceuticals, Inc. Company Details
Table 115. Inovio Pharmaceuticals, Inc. Business Overview
Table 116. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Services
Table 117. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 118. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery SWOT Analysis
Table 119. Inovio Pharmaceuticals, Inc. Recent Developments
Table 120. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
Table 121. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
Table 122. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product and Services
Table 123. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 124. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments
Table 125. MedPharm LTD Company Details
Table 126. MedPharm LTD Business Overview
Table 127. MedPharm LTD Transmucosal Drug Delivery Product and Services
Table 128. MedPharm LTD Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 129. MedPharm LTD Recent Developments
Table 130. Mylan, Inc. Company Details
Table 131. Mylan, Inc. Business Overview
Table 132. Mylan, Inc. Transmucosal Drug Delivery Product and Services
Table 133. Mylan, Inc. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 134. Mylan, Inc. Recent Developments
Table 135. Nemaura Pharma Ltd Company Details
Table 136. Nemaura Pharma Ltd Business Overview
Table 137. Nemaura Pharma Ltd Transmucosal Drug Delivery Product and Services
Table 138. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 139. Nemaura Pharma Ltd Recent Developments
Table 140. Nitto Denko Corporation Company Details
Table 141. Nitto Denko Corporation Business Overview
Table 142. Nitto Denko Corporation Transmucosal Drug Delivery Product and Services
Table 143. Nitto Denko Corporation Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 144. Nitto Denko Corporation Recent Developments
Table 145. Noven Pharmaceuticals, Inc. Company Details
Table 146. Noven Pharmaceuticals, Inc. Business Overview
Table 147. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Services
Table 148. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 149. Noven Pharmaceuticals, Inc. Recent Developments
Table 150. Pantec Biosolutions AG Company Details
Table 151. Pantec Biosolutions AG Business Overview
Table 152. Pantec Biosolutions AG Transmucosal Drug Delivery Product and Services
Table 153. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 154. Pantec Biosolutions AG Recent Developments
Table 155. Tapemark Company Details
Table 156. Tapemark Business Overview
Table 157. Tapemark Transmucosal Drug Delivery Product and Services
Table 158. Tapemark Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 159. Tapemark Recent Developments
Table 160. tesa Labtec GmbH Company Details
Table 161. tesa Labtec GmbH Business Overview
Table 162. tesa Labtec GmbH Transmucosal Drug Delivery Product and Services
Table 163. tesa Labtec GmbH Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 164. tesa Labtec GmbH Recent Developments
Table 165. TEVA Pharmaceutical Industries Ltd. Company Details
Table 166. TEVA Pharmaceutical Industries Ltd. Business Overview
Table 167. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product and Services
Table 168. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 169. TEVA Pharmaceutical Industries Ltd. Recent Developments
Table 170. Zosano Pharma Company Details
Table 171. Zosano Pharma Business Overview
Table 172. Zosano Pharma Transmucosal Drug Delivery Product and Services
Table 173. Zosano Pharma Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 174. Zosano Pharma Recent Developments
Table 175. Transmucosal Drug Delivery Market Trends
Table 176. Transmucosal Drug Delivery Market Drivers
Table 177. Transmucosal Drug Delivery Market Challenges
Table 178. Transmucosal Drug Delivery Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transmucosal Drug Delivery Sales Market Share by Type: 2021 VS 2028
Figure 2. Passive Transdermal Drug Delivery Features
Figure 3. Active Transdermal Drug Delivery Features
Figure 4. Global Transmucosal Drug Delivery Sales Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Transmucosal Drug Delivery Report Years Considered
Figure 9. Global Transmucosal Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Transmucosal Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 11. Global Transmucosal Drug Delivery Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Transmucosal Drug Delivery Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Transmucosal Drug Delivery Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Transmucosal Drug Delivery Market Share by Players in 2021
Figure 15. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2021
Figure 17. North America Transmucosal Drug Delivery Revenue Market Share by Company in 2021
Figure 18. North America Transmucosal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 19. North America Transmucosal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 20. North America Transmucosal Drug Delivery Revenue Share by Country (2017-2028)
Figure 21. U.S. Transmucosal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Transmucosal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Transmucosal Drug Delivery Revenue Market Share by Company in 2021
Figure 24. Europe Transmucosal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 25. Europe Transmucosal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 26. Europe Transmucosal Drug Delivery Revenue Share by Country (2017-2028)
Figure 27. Germany Transmucosal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 28. France Transmucosal Dru
  • Global Gold Nanoparticles Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121
    Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
  • Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Gold Nanoparticles Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
  • Global Liposome Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
  • Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
  • Global Liposomes Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
  • Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129
    According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
  • Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs